Homing potential of the antigen specific B cell and antibody mediated immune response after vaccination Spesifisten B solujen kotiutumispotentiaali ja vasta-aine vaste rokotetuilla

Trial Profile

Homing potential of the antigen specific B cell and antibody mediated immune response after vaccination Spesifisten B solujen kotiutumispotentiaali ja vasta-aine vaste rokotetuilla

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 21 Apr 2012

At a glance

  • Drugs Cholera vaccine inactivated (Primary) ; Influenza A virus vaccine-H1N1 (Primary) ; Influenza virus vaccine (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate (Primary) ; Typhoid vaccine Vi-polysaccharide (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate; Pneumococcal vaccine; Typhoid-vaccine-Ty21a
  • Indications Cholera; Influenza A virus H1N1 subtype; Influenza virus infections; Pneumococcal infections; Typhoid
  • Focus Pharmacodynamics
  • Most Recent Events

    • 21 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top